Altium Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 148 |
|
|
2022
Q2 | – | Sell |
-386,000
| Closed | -$9.14M | – | 135 |
|
|
2022
Q1 | $9.14M | Buy |
386,000
+40,000
| +12% | +$947K | 3.06% | 3 |
|
|
2021
Q4 | $11.8M | Hold |
346,000
| – | – | 3.26% | 2 |
|
|
2021
Q3 | $6.13M | Buy |
346,000
+63,555
| +23% | +$1.13M | 1.61% | 13 |
|
|
2021
Q2 | $12.7M | Buy |
282,445
+44,091
| +18% | +$1.98M | 2.94% | 3 |
|
|
2021
Q1 | $6.17M | Buy |
238,354
+52,500
| +28% | +$1.36M | 1.71% | 8 |
|
|
2020
Q4 | $3.75M | Buy |
+185,854
| New | +$3.75M | 1.4% | 27 |
|